Study: J&J's stent better than Boston Scientific's

09/13/2007 | NYTimes.com

Patients who received Johnson & Johnson's Cypher drug-coated stent were less likely to suffer heart attacks than patients who received Boston Scientific Corp.'s Taxus stent and bare-metal stents, a study revealed. Researchers also found that Taxus stents slightly increased the risk of fatal clots in patients compared with Cypher and bare-metal stents.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC